Glaukos Corp (GKOS) director Kliman receives new RSU and option awards
Rhea-AI Filing Summary
GLAUKOS Corp director Gilbert H. Kliman received new equity awards as part of the company’s director compensation program. He was granted 1,878 shares of common stock in the form of restricted stock units that vest in full on the one-year anniversary of the grant date and will be settled in an equal number of shares.
He also received a stock option for 2,987 shares of common stock with an exercise price of $53.57 per share, vesting in full one year after the grant and expiring on May 28, 2036. After these awards, Kliman directly holds 37,406 shares of common stock. Footnote disclosure states this total includes 4,609 restricted stock units that are either unvested or vested but with delivery deferred.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 2,987 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,878 | $0.00 | $0.00 |
Footnotes (3)
- F1. Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock.
- F2. Includes 4,609 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person.
- F3. Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date.
Key Figures
Key Terms
restricted stock units financial
Director Compensation Policy financial
Stock Option (Right to Buy) financial
exercise price financial
grant, award, or other acquisition regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.